At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Magseed and Sentimagdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization
In Brief
A clinical study evaluating Magseed and Sentimag for Disorders of Breast and Breast Lesions. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDisorders of Breast, Breast Lesions
CountriesUnited States
CollaboratorsM.D. Anderson Cancer Center
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJan 2017
First PostedJan 2017
Primary CompletionFeb 2018
Study CompletionJul 2018
TodayJul 2026
First PostedJan 13, 2017
Enrollment StartJan 1, 2017
Primary CompletionFeb 1, 2018
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.5 years ago
Interventions
Magseed and Sentimagdevice
Magseed marker and Sentimag probe for lesion localization